Literature DB >> 25615971

Expression, purification and crystallization of a membrane-associated, catalytically active type I signal peptidase from Staphylococcus aureus.

Yi Tian Ting1, Gaëlle Batot1, Edward N Baker1, Paul G Young1.   

Abstract

Staphylococcus aureus infections are becoming increasingly difficult to treat as they rapidly develop resistance to existing antibiotics. Bacterial type I signal peptidases are membrane-associated, cell-surface serine proteases with a unique catalytic mechanism that differs from that of eukaryotic endoplasmic reticulum signal peptidases. They are thus potential antimicrobial targets. S. aureus has a catalytically active type I signal peptidase, SpsB, that is essential for cell viability. To elucidate its structure, the spsB gene from S. aureus Newman strain was cloned and overexpressed in Escherichia coli. After exploring many different protein-modification constructs, SpsB was expressed as a fusion protein with maltose-binding protein and crystallized by hanging-drop vapour diffusion. The crystals belonged to the monoclinic space group P2(1) and diffracted to 2.05 Å resolution. The crystal structure of SpsB is anticipated to provide structural insight into Gram-positive signal peptidases and to aid in the development of antibacterial agents that target type I signal peptidases.

Entities:  

Keywords:  SpsB; Staphylococcus aureus; cell secretion; maltose-binding fusion protein; type I signal peptidase

Mesh:

Substances:

Year:  2015        PMID: 25615971      PMCID: PMC4304750          DOI: 10.1107/S2053230X1402603X

Source DB:  PubMed          Journal:  Acta Crystallogr F Struct Biol Commun        ISSN: 2053-230X            Impact factor:   1.056


  20 in total

Review 1.  Bacterial type I signal peptidases as antibiotic targets.

Authors:  C V Smitha Rao; Jozef Anné
Journal:  Future Microbiol       Date:  2011-11       Impact factor: 3.165

Review 2.  Membrane proteases in the bacterial protein secretion and quality control pathway.

Authors:  Ross E Dalbey; Peng Wang; Jan Maarten van Dijl
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

3.  Broad-spectrum antibiotic activity of the arylomycin natural products is masked by natural target mutations.

Authors:  Peter A Smith; Tucker C Roberts; Floyd E Romesberg
Journal:  Chem Biol       Date:  2010-11-24

4.  Mechanism of action of the arylomycin antibiotics and effects of signal peptidase I inhibition.

Authors:  Peter A Smith; Floyd E Romesberg
Journal:  Antimicrob Agents Chemother       Date:  2012-07-16       Impact factor: 5.191

5.  Linking crystallographic model and data quality.

Authors:  P Andrew Karplus; Kay Diederichs
Journal:  Science       Date:  2012-05-25       Impact factor: 47.728

6.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

Review 7.  Signal peptidase I: cleaving the way to mature proteins.

Authors:  Sarah M Auclair; Meera K Bhanu; Debra A Kendall
Journal:  Protein Sci       Date:  2011-11-22       Impact factor: 6.725

8.  Molecular cloning and expression of the spsB gene encoding an essential type I signal peptidase from Staphylococcus aureus.

Authors:  K M Cregg; I Wilding; M T Black
Journal:  J Bacteriol       Date:  1996-10       Impact factor: 3.490

9.  Crystallographic and biophysical analysis of a bacterial signal peptidase in complex with a lipopeptide-based inhibitor.

Authors:  Mark Paetzel; Jonathon J Goodall; Malgosia Kania; Ross E Dalbey; Malcolm G P Page
Journal:  J Biol Chem       Date:  2004-05-10       Impact factor: 5.157

Review 10.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14
View more
  2 in total

1.  Engineering a Lys-Asn isopeptide bond into an immunoglobulin-like protein domain enhances its stability.

Authors:  Hanna Kwon; Paul G Young; Christopher J Squire; Edward N Baker
Journal:  Sci Rep       Date:  2017-02-16       Impact factor: 4.379

2.  Complement evasion factor (CEF), a novel immune evasion factor of Streptococcus pyogenes.

Authors:  Haniyeh Aghababa; Yi Tian Ting; Devaki Pilapitiya; Jacelyn M S Loh; Paul G Young; Thomas Proft
Journal:  Virulence       Date:  2022-12       Impact factor: 5.882

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.